Hepatitis C virus (HCV) infection is the most common blood-borne infection in the United
States, with estimates of 4 million HCV-infected individuals in the United States and 170 million …

Background The hepatitis C virus (HCV) is a major public health problem and a leading
cause of chronic liver disease. In the United States, the Centers for Disease Control and …

Background The hepatitis C virus (HCV) is a major public health problem and a leading
cause of chronic liver disease. 5 An estimated 180 million people are infected worldwide. 6 In …

Methods. Of the 868 patients enrolled in APRICOT, 832 were included in the analysis. Thirty‐six
patients were excluded because of lack of interpretable histology. Liver histology was …

Designing Practice Guidelines; 1 (3) guideline policies, including the AASLD Policy on the
Development and Use of Practice Guidelines and the American Gastroenterological …

ContextHepatitis C virus (HCV) infection may resolve (viral clearance), persist without
complications, or cause end-stage liver disease (ESLD). The frequency and determinants of these …

Natural killer (NK) cells provide a central defense against viral infection by using inhibitory
and activation receptors for major histocompatibility complex class I molecules as a means of …

Medical imaging has enormous potential for early disease prediction, but is impeded by the
difficulty and expense of acquiring data sets before symptom onset. UK Biobank aims to …

Background Although coinfection with HIV-1 and hepatitis B virus (HBV) is common, few
long-term studies on liver-disease mortality in coinfected people have been undertaken. Our …

ContextUse of antiretroviral drugs, including protease inhibitors, for treatment of human
immunodeficiency virus (HIV) infection has been anecdotally associated with hepatotoxicity, …